Assessing Vertex Pharmaceuticals: Insights From 15 Financial Analysts

Ratings for Vertex Pharmaceuticals (NASDAQ: VRTX) were provided by 15 analysts in the past three months, showcasing a mix of ...
IEEE

EDG-Net: Edge-Enhanced Dynamic Graph Convolutional Network for Remote Sensing Scene Classification of Mining-Disturbed Land

Abstract: Scene classification and mapping of surface mining-disturbed land can attain semantic-level information that is useful for monitoring mine geo-environment. Mining land’s complex ...
IEEE

ES-GNN: Generalizing Graph Neural Networks Beyond Homophily With Edge Splitting

Abstract: While Graph Neural Networks (GNNs) have achieved enormous success in multiple graph analytical tasks, modern variants mostly rely on the strong inductive bias of homophily. However, ...

The AI Inference Economy - What Is Edge AI, Exactly?

Companies within the ROBO Global Robotics and Automation Index and the ROBO Global Artificial Intelligence Index sit at the ...

Vertex Pharmaceuticals: I'm Downgrading To Hold On Drug Pricing, Pipeline Concerns

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.
Zacks Investment Research on MSN

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

FDA Grants Vertex Kidney Disease Drug Breakthrough Therapy Designation

The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
Zacks Investment Research on MSN

Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...